ArticleCurrent oncology (Toronto, Ont.)2022

Predicting Early Disease Recurrence of Pancreatic Cancer following Surgery: Determining the Role of NUDT15 as a Prognostic Biomarker.

Daniel Llwyd Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.